12:00 AM
Jun 12, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Trospium chloride: Began Phase III trial

Interneuron Pharmaceuticals Inc. (IPIC), Lexington, Mass.
Product: Trospium chloride
Business: Urological
Therapeutic category: Receptor antagonist
Target: Muscarinic receptors
Description: Muscarinic...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >